about
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific T...
Read More
10.25
0.19
(1.89%)
1.1M
XNAS Volume
XNAS 17 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Immix Biopharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..